• Protein A/G Magnetic Beads: Practical IP Guide

  2026-09-02

  Protein A/G Magnetic Beads provide Fc-directed capture for antibody purification, immunoprecipitation, co-immunoprecipitation, and chromatin workflows from complex samples. This guide explains setup, controls, and troubleshooting while defining limits for Fc-lacking antibody fragments, unvalidated assay conditions, and diagnostic or medical use.

• FGFR3 Inhibition in SLC26A2 Chondrodysplasia

  2026-09-01

  The reference study combines genetic models, inducible postnatal deletion, chondrocyte assays, and pharmacological inhibition to show that excessive FGFR3 signaling contributes to SLC26A2-related skeletal dysplasia in mice. Its findings support FGFR3 pathway inhibition as a research direction for improving chondrocyte differentiation, survival, and bone microarchitecture, while leaving human efficacy and dosing questions unresolved.

• Rotenone and Mitochondria-to-Peroxisome Stress

  2026-09-01

  Rotenone is best known as a mitochondrial Complex I inhibitor, but its value extends to studying how mitochondrial stress may intersect with organelle quality control. This article translates new findings on MARCH5-dependent pre-peroxisome formation into a practical framework for designing mechanistically separated rotenone assays.

• BODIPY 581/591 C11 for Lipid Peroxidation

  2026-08-31

  BODIPY 581/591 C11 converts membrane oxidation into a measurable red-to-green fluorescence ratio, supporting live-cell lipid peroxidation detection without relying on a single intensity value. This workflow guide shows how to apply the probe to antioxidant capacity evaluation, nanozyme studies, and cardiovascular oxidative stress experiments while avoiding common interpretation errors.

• HyperFusion high-fidelity DNA polymerase for C. elegans PCR

  2026-08-31

  HyperFusion™ high-fidelity DNA polymerase combines proofreading accuracy with robust amplification of GC-rich, long, or inhibitor-containing templates. This article shows how to apply it to C. elegans genotyping, cloning, targeted sequencing, and mechanistic studies inspired by pheromone-linked neurodegeneration research.

• Thioguanine: Reproducible Cell Assay Workflows

  2026-08-30

  This scenario-driven guide explains how Thioguanine, SKU A4176, can reduce common formulation, dosing, and interpretation problems in cell viability, proliferation, and antiviral assays. It connects product handling data with published EV71 results and practical controls for more defensible laboratory decisions.

• Tankyrase Inhibitors and Hippo Signaling in HCC

  2026-08-29

  Jia et al. showed that XAV-939 and G007-LK suppress hepatocellular carcinoma cell growth through a mechanism involving AMOTL1/2 stabilization, reduced YAP activity, and inhibition of the Hippo effector program. The study broadens interpretation of tankyrase inhibition beyond Wnt/β-catenin signaling and provides a rationale for testing combinations with MEK or AKT pathway inhibitors.

• FGFR3 Signaling in SLC26A2 Chondrodysplasia

  2026-08-28

  This study combines genetic models, inducible disease modeling, and pharmacological intervention to show that excessive FGFR3 signaling contributes to SLC26A2-related chondrodysplasia in mice. Its findings support NVP-BGJ398 as a mechanistic research tool and provide preclinical evidence for targeting FGFR3 to improve chondrocyte function and skeletal development.

• Rotenone Workflows for Mitochondrial Stress Research

  2026-08-28

  Rotenone provides a controlled way to connect mitochondrial Complex I inhibition with ROS, ATP loss, apoptosis, and stress signaling. This practical guide combines cell-based workflows, Parkinson’s disease model considerations, and a reference-informed strategy for testing how mitochondrial ROS may influence NEMO–RelA signaling.

• Cy3 TSA Fluorescence System Kit for OR Studies

  2026-08-27

  Map low-abundance olfactory receptor proteins or transcripts in fixed cells and tissue with localized Cy3 tyramide signal amplification. This workflow connects structural receptor biology with practical IHC, ICC, and ISH readouts while preserving the critical distinction between expression mapping and functional ligand activation.

• Firefly Luciferase mRNA as a Delivery Stress Test

  2026-08-27

  A thought-leadership guide to using capped, modified Firefly Luciferase mRNA as a mechanistic benchmark for RNA delivery, translation, endosomal escape, and translational assay development.

• Rotenone Workflows for Mitochondrial Stress

  2026-08-26

  Use Rotenone as a mechanistically anchored mitochondrial Complex I inhibitor to connect ATP loss, ROS elevation, apoptosis, and neuronal injury in controlled workflows. This guide also shows how to pair rotenone mitochondrial stress assays with emerging mitochondrial proteostasis research on TCAIM and OGDH.

• HotStart Universal 2X Green qPCR Master Mix: Evidence

  2026-08-26

  HotStart Universal 2X Green qPCR Master Mix supports reproducible gene expression quantification with hot-start specificity, Green I fluorescence, and universal ROX normalization. This article presents an evidence-centered workflow for translating NEXMIF overexpression findings into defensible real-time PCR gene expression analysis.

• Anti-RPS6 Antibody: Reliable Cell Assays

  2026-08-25

  This scenario-driven guide explains how Anti-RPS6 (7B10) Mouse Monoclonal Antibody, SKU MA4974, can complement viability, proliferation, and cytotoxicity assays by tracking RPS6 in lysates, fixed cells, and immunoprecipitates. It separates product-supported specifications from laboratory optimization and connects RPS6 measurements with recent evidence on ribosome biogenesis and PDAC growth.

• BZYQD–PCBP1 Mechanism of Cisplatin Resistance

  2026-08-25

  A 2025 Journal of Ethnopharmacology study identifies PCBP1 suppression and ferritinophagy-mediated ferroptosis as a mechanism by which Buzhong Yiqi Decoction improves Cisplatin sensitivity in A549/DDP non-small cell lung cancer cells. Its integrated use of ferroptosis profiling, lipid peroxidation assays, ultrastructural analysis, and PCBP1 overexpression provides a mechanistic framework for studying resistance reversal, while also highlighting the need for validation in animal and patient-derived models.

7918 records 1/528 page Next 12345 下5页 Last page